"description","id","text","label","instanceType","name","uuid:ID"
"Main objective","Objective_1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","","Objective","OBJ1","0e1bbb78-77f1-4c38-8db7-e4ab6bb17743"
"Safety","Objective_2","To document the safety profile of the xanomeline TTS.","","Objective","OBJ2","538010b5-60c9-4a74-a2ba-d1ea984dc73a"
"Behaviour","Objective_3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","","Objective","OBJ3","3c9e892c-13d7-45df-80a1-fe0dcd7d202d"
